1. Home
  2. ABBV
  3. ABBV News

Latest AbbVie Inc. (ABBV) News on July 2, 2024

2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
ABBV

Motley Fool

21 hours ago

2 High-Yielding Healthcare Stocks to Buy With $1,000 in July

ABBV

MT Newswires

a day ago

AbbVie Says Robert Michael Assumes CEO Role

AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
ABBV

Zacks

a day ago

AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use

Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
ABBV

PR Newswire

a day ago

Robert A. Michael Assumes Role as AbbVie Chief Executive Officer

3 Magnificent Stocks Retirees Can Buy and Hold Forever
ABBV

Motley Fool

a day ago

3 Magnificent Stocks Retirees Can Buy and Hold Forever

10 clinical trials to watch in the second half of 2024
ABBV

BioPharma Dive

a day ago

10 clinical trials to watch in the second half of 2024

How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
ABBV

Benzinga

3 days ago

How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?

How Medicare drug price negotiations could hit pharma stocks
ABBV

Yahoo Finance Video

4 days ago

How Medicare drug price negotiations could hit pharma stocks

Coherus offloads Humira biosimilar Yusimry for $40m
ABBV

Pharmaceutical Technology

4 days ago

Coherus offloads Humira biosimilar Yusimry for $40m

AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
ABBV

Simply Wall St.

4 days ago

AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy

Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
ABBV

Zacks

4 days ago

Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN

AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
ABBV

Zacks

4 days ago

AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
ABBV

Zacks

4 days ago

Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

AbbVie completes acquisition of Celsius Therapeutics for $250m
ABBV

Pharmaceutical Technology

4 days ago

AbbVie completes acquisition of Celsius Therapeutics for $250m

ABBV

MT Newswires

4 days ago

AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment

AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
ABBV

PR Newswire

4 days ago

AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma

ABBV

MT Newswires

5 days ago

Sector Update: Health Care Stocks Slipping Late Afternoon

ABBV

MT Newswires

5 days ago

Sector Update: Health Care Stocks Decline in Afternoon Trading

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
ABBV

Zacks

5 days ago

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma

Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection
ABBV

Zacks

5 days ago

Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection

ABBV

MT Newswires

5 days ago

Update: AbbVie Buys Celsius Therapeutics for $250 million

ABBV

MT Newswires

5 days ago

AbbVie Buys Celsius Therapeutics for $250 million

AbbVie Acquires Celsius Therapeutics
ABBV

PR Newswire

5 days ago

AbbVie Acquires Celsius Therapeutics

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
ABBV

Zacks

5 days ago

Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?

Introducing Allē Payment Plans, Powered by Cherry
ABBV

PR Newswire

5 days ago

Introducing Allē Payment Plans, Powered by Cherry

Can AbbVie Stock Keep Outpacing the S&P 500?
ABBV

Motley Fool

5 days ago

Can AbbVie Stock Keep Outpacing the S&P 500?

AbbVie gains FDA approval for EPKINLY in follicular lymphoma
ABBV

Pharmaceutical Technology

5 days ago

AbbVie gains FDA approval for EPKINLY in follicular lymphoma

U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma
ABBV

PR Newswire

6 days ago

U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma

AbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection
ABBV

Zacks

6 days ago

AbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection

Zealand hauls in $1B off obesity drug data; Curie.bio zeroes in on Series A’s
ABBV

BioPharma Dive

6 days ago

Zealand hauls in $1B off obesity drug data; Curie.bio zeroes in on Series A’s

FDA issues complete response to AbbVie’s NDA for Parkinson’s drug
ABBV

Pharmaceutical Technology

6 days ago

FDA issues complete response to AbbVie’s NDA for Parkinson’s drug

AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
ABBV

Zacks

7 days ago

AbbVie (ABBV) Stock Dips While Market Gains: Key Facts

AbbVie's Parkinson's Disease Therapy Hits FDA Roadblock
ABBV

Benzinga

7 days ago

AbbVie's Parkinson's Disease Therapy Hits FDA Roadblock

ABBV

MT Newswires

7 days ago

AbbVie Issues Regulatory Update on New Drug Application for ABBV-951 to Treat Parkinson's Disease

AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)
ABBV

PR Newswire

7 days ago

AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)

ASCO24: AbbVie flexes early success of ADC pipeline in solid tumours
ABBV

Clinical Trials Arena

7 days ago

ASCO24: AbbVie flexes early success of ADC pipeline in solid tumours

The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value
ABBV

GuruFocus.com

7 days ago

The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value

3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
ABBV

Motley Fool

7 days ago

3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income

Here's Why You Should Consider Buying Alvotech (ALVO) Stock
ABBV

Zacks

8 days ago

Here's Why You Should Consider Buying Alvotech (ALVO) Stock

If You Invested $1000 in AbbVie a Decade Ago, This is How Much It'd Be Worth Now
ABBV

Zacks

8 days ago

If You Invested $1000 in AbbVie a Decade Ago, This is How Much It'd Be Worth Now

Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
ABBV

Zacks

11 days ago

Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs

AbbVie Declares Quarterly Dividend
ABBV

PR Newswire

11 days ago

AbbVie Declares Quarterly Dividend

ABBV

MT Newswires

12 days ago

AbbVie Says Skyrizi Gets FDA Approval For Ulcerative Colitis

10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year
ABBV

Motley Fool

12 days ago

10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year

AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors
ABBV

PR Newswire

12 days ago

AbbVie Appoints Roxanne S. Austin as Lead Independent Director of the Board of Directors

Why AbbVie (ABBV) is a Great Dividend Stock Right Now
ABBV

Zacks

13 days ago

Why AbbVie (ABBV) is a Great Dividend Stock Right Now

Here's Why AbbVie (ABBV) is a Strong Momentum Stock
ABBV

Zacks

13 days ago

Here's Why AbbVie (ABBV) is a Strong Momentum Stock

AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
ABBV

Zacks

13 days ago

AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis

2 Super Smart Dividend Stocks to Buy With $10,000 Right Now
ABBV

Motley Fool

13 days ago

2 Super Smart Dividend Stocks to Buy With $10,000 Right Now

AbbVie’s SKYRIZI gains US FDA approval for ulcerative colitis
ABBV

Pharmaceutical Technology

13 days ago

AbbVie’s SKYRIZI gains US FDA approval for ulcerative colitis

U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease
ABBV

PR Newswire

14 days ago

U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease

AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
ABBV

Zacks

14 days ago

AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider

Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression
ABBV

Clinical Trials Arena

14 days ago

Intra-Cellular Therapies edges closer to FDA win for Caplyta in depression

Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
ABBV

Zacks

14 days ago

Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study

Humira: the highs and lows of the world’s best-selling drug
ABBV

Pharmaceutical Technology

14 days ago

Humira: the highs and lows of the world’s best-selling drug

ABBV

MT Newswires

14 days ago

Piper Sandler Adjusts Price Target on AbbVie to $190 From $185

2 Dividend Stocks That Could Pay You for Life
ABBV

Motley Fool

16 days ago

2 Dividend Stocks That Could Pay You for Life

ABBV

MT Newswires

18 days ago

AbbVie Says Investors Should Sit Out Tutanota Mini-Tender Offer

AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer
ABBV

PR Newswire

18 days ago

AbbVie Recommends Shareholders Reject Tutanota's "Mini-Tender" Offer

Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
ABBV

Zacks

18 days ago

Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails

AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
ABBV

Zacks

18 days ago

AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate

AbbVie joins in latest gastrointestinal drug chase
ABBV

BioPharma Dive

18 days ago

AbbVie joins in latest gastrointestinal drug chase

AbbVie and FutureGen link on inflammatory bowel disease
ABBV

Pharmaceutical Technology

18 days ago

AbbVie and FutureGen link on inflammatory bowel disease

Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends
ABBV

Benzinga

19 days ago

Here's How Many Shares Of AbbVie You Would Need To Earn $500 Per Month In Dividends

ABBV

MT Newswires

19 days ago

AbbVie, FutureGen to Develop Potential Inflammatory Bowel Disease Treatment

AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease
ABBV

PR Newswire

19 days ago

AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory Bowel Disease

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
ABBV

Zacks

20 days ago

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value
ABBV

GuruFocus.com

21 days ago

The Art of Valuation: Discovering AbbVie Inc's Intrinsic Value

BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients
ABBV

PR Newswire

21 days ago

BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients

AbbVie (ABBV) Laps the Stock Market: Here's Why
ABBV

Zacks

22 days ago

AbbVie (ABBV) Laps the Stock Market: Here's Why

Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
ABBV

Zacks

25 days ago

Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval

AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
ABBV

Zacks

25 days ago

AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal

Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
ABBV

BioPharma Dive

25 days ago

Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO

AbbVie reports positive Phase II ovarian cancer trial data
ABBV

Clinical Trials Arena

25 days ago

AbbVie reports positive Phase II ovarian cancer trial data

Is AbbVie Inc. (NYSE:ABBV) the Most Undervalued Dividend Aristocrat Stock According to Analysts?
ABBV

Insider Monkey

a month ago

Is AbbVie Inc. (NYSE:ABBV) the Most Undervalued Dividend Aristocrat Stock According to Analysts?

AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
ABBV

Zacks

a month ago

AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug

ABBV

MT Newswires

a month ago

AbbVie Says Mid-Stage Study of Mirvetuximab Soravtansine to Treat Ovarian Cancer Meets Primary Endpoint

AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine (ELAHERE®) for High Folate Receptor-Alpha (FRα) Expressing Platinum-Sensitive Ovarian Cancer
ABBV

PR Newswire

a month ago

AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab Soravtansine (ELAHERE®) for High Folate Receptor-Alpha (FRα) Expressing Platinum-Sensitive Ovarian Cancer

SkinMedica® Celebrates 25 Years of Empowering Radiant Skin
ABBV

PR Newswire

a month ago

SkinMedica® Celebrates 25 Years of Empowering Radiant Skin

AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers
ABBV

PR Newswire

a month ago

AbbVie Launches First-of-its-Kind Contest to Empower People Living with Migraine in their Careers

AbbVie treats first subject in Phase III multiple myeloma drug trial
ABBV

Clinical Trials Arena

a month ago

AbbVie treats first subject in Phase III multiple myeloma drug trial

ABBV

MT Newswires

a month ago

AbbVie Says First Patient Treated in Phase 3 Trial Assessing Potential Blood Cancer Treatment

2 High-Yield Dividend Stocks to Buy Right Now
ABBV

Motley Fool

a month ago

2 High-Yield Dividend Stocks to Buy Right Now

AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383
ABBV

PR Newswire

a month ago

AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383

Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
ABBV

BioPharma Dive

a month ago

Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks

AbbVie’s RINVOQ now indicated for paediatric arthritis in US
ABBV

Pharmaceutical Technology

a month ago

AbbVie’s RINVOQ now indicated for paediatric arthritis in US

ABBV

MT Newswires

a month ago

HSBC Upgrades AbbVie to Buy From Hold, Adjusts Price Target to $185 From $161

3 Dividend Stocks You May Want To Double Down On
ABBV

Benzinga

a month ago

3 Dividend Stocks You May Want To Double Down On

ABBV

MT Newswires

a month ago

AbbVie Says Arthritis Treatment Rinvoq Now Available for Certain Pediatric Patients in US

Top Stocks to Buy in June
ABBV

Motley Fool

a month ago

Top Stocks to Buy in June

RINVOQ® (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis
ABBV

PR Newswire

a month ago

RINVOQ® (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis

Refer Your Friends to Allē, the Loyalty Rewards Program by Allergan Aesthetics, and Earn $50
ABBV

PR Newswire

a month ago

Refer Your Friends to Allē, the Loyalty Rewards Program by Allergan Aesthetics, and Earn $50

AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
ABBV

Zacks

a month ago

AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know

AbbVie (ABBV) Could Be a Great Choice
ABBV

Zacks

a month ago

AbbVie (ABBV) Could Be a Great Choice

AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
ABBV

Zacks

a month ago

AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU

AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
ABBV

PR Newswire

a month ago

AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
ABBV

Clinical Trials Arena

a month ago

ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours

AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?
ABBV

Zacks

a month ago

AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?

3 No-Brainer Stocks to Buy in June
ABBV

Motley Fool

a month ago

3 No-Brainer Stocks to Buy in June

Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
ABBV

Zacks

a month ago

Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal

Share on Social Networks: